So, what can you expect from AiCure in the future. Well, I don't have enough time to answer all the things that I'm excited about, but just to give one little teaser that we're working on, is the eradication of HIV and AIDS, and utilizing our technology, as well as preventative medicines that have been created, and ensuring that patients have access to that medication, or taking that medication, and receiving real time feedback. But as of now, AiCure is monitoring patient behavior and outcomes, and monitoring whether or not patients take their medication. But, what's really exciting, and what you'll see from AiCure within the next three years as we develop more data sets, and understand the data coming in, is that we'll be able to predict things, like outcomes, and we'll be able to predict what types of treatments would fit which patient population best. So, you could be a patient with major depressive disorder, and there's something in major depressive disorder in patients with depression, that is called treatment-resistant depression, meaning that no medication that they've tried, and there is, you know, tens of them, hundreds of them out there, have ever worked, but potentially with our technology, we'll be able to tell based on that patient's profile, including facial expressions, voice recognition, and digital buyer biomarkers, what types of medications might be suitable for relieving their depression, and that's just one example, and we want to take this into all of the disease areas that we work within, the psychiatry, neurology, infectious diseases, liver diseases, metabolic diseases, and a whole host of other diseases that I don't have time to name right now. But, the idea is to be able to predict which medications work best, be able to predict patient outcomes, and be able to predict patient behaviors related to those medications. So, that's something I'm very excited about.